The Food and Drug Administration (FDA) has approved a continuous glucose and ketone monitoring system, which it says is the first wearable device that monitors both levels simultaneously with a single sensor. The system measures glucose and ketones in interstitial fluid every minute for up to 10 days and transmits the information to the patient’s smartphone. Patients arriving in urgent care will be able to present not just current ketone readings but the direction and …
Read More